Dr. Geschwind founded a biotech company focused on glycolysis-targeting cancer drugs, advancing novel therapeutic options for liver and pancreas tumors. https://www.bumc.bu.edu/camed/offices-services/alumni/alumni-recognition-resources/alumni-awards-submission/past-recipients-of-the-alumni-awards/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/